Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers

被引：0
|
作者：
Schlosser, Shir
Molho, Rinat Bernstein
Karminsky, Natalia
Barsuk, Daphna
Goldberg, Yael
Friedman, Eitan
Yerushalmi, Rinat
Drumea, Keren
Kedar, Inbal
Jiveliouk, Irina
Ben David, Merav Akiva
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-09-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-16
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prevalence of the CHEK2 R95* germline mutation
    Stian Knappskog
    Beryl Leirvaag
    Liv B. Gansmo
    Pål Romundstad
    Kristian Hveem
    Lars Vatten
    Per E. Lønning
    Hereditary Cancer in Clinical Practice, 14
  • [32] Prevalence of the CHEK2 R95*germline mutation
    Knappskog, Stian
    Leirvaag, Beryl
    Gansmo, Liv B.
    Romundstad, Pal
    Hveem, Kristian
    Vatten, Lars
    Lonning, Per E.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2016, 14
  • [33] Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hollestelle, Antoinette
    Berns, Els M. J. J.
    Blom, Jannet
    Meijer-van Gelder, Marion E.
    Sieuwerts, Anieta M.
    van den Ouweland, Ans
    Collee, J. Margriet
    Kroep, Judith R.
    Martens, John W. M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (10) : 1879 - 1887
  • [34] Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
    Kleiblova, Petra
    Stolarova, Lenka
    Krizova, Katerina
    Lhota, Filip
    Hojny, Jan
    Zemankova, Petra
    Havranek, Ondrej
    Vocka, Michal
    Cerna, Marta
    Lhotova, Klara
    Borecka, Marianna
    Janatova, Marketa
    Soukupova, Jana
    Sevcik, Jan
    Zimovjanova, Martina
    Kotlas, Jaroslav
    Panczak, Ales
    Vesela, Kamila
    Cervenkova, Jana
    Schneiderova, Michaela
    Burocziova, Monika
    Burdova, Kamila
    Stranecky, Viktor
    Foretova, Lenka
    Machackova, Eva
    Tavandzis, Spiros
    Kmoch, Stanislav
    Macurek, Libor
    Kleibl, Zdenek
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1782 - 1797
  • [35] Germline variant profiling of CHEK2 sequencing variants in breast cancer patients
    McCarthy-Leo, Claire
    Baughan, Scott
    Dlugas, Hunter
    Abraham, Prisca
    Gibbons, Janice
    Baldwin, Carolyn
    Chung, Sarah
    Feldman, Gerald L.
    Dyson, Gregory
    Finley Jr, Russell L.
    Tainsky, Michael A.
    CANCER GENETICS, 2024, 288 : 10 - 19
  • [36] CHEK2 and breast cancer risk
    Coupier, I
    Stoppa-Lyonnet, D
    BULLETIN DU CANCER, 2002, 89 (11) : 921 - 922
  • [37] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    L Mellemkjær
    C Dahl
    J H Olsen
    L Bertelsen
    P Guldberg
    J Christensen
    A-L Børresen-Dale
    M Stovall
    B Langholz
    L Bernstein
    C F Lynch
    K E Malone
    R W Haile
    M Andersson
    D C Thomas
    P Concannon
    M Capanu
    J D Boice
    J L Bernstein
    British Journal of Cancer, 2008, 98 : 728 - 733
  • [38] Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
    Mellemkjaer, L.
    Dahl, C.
    Olsen, J. H.
    Bertelsen, L.
    Guldberg, P.
    Christensen, J.
    Borresen-Dale, A-L
    Stovall, M.
    Langholz, B.
    Bernstein, L.
    Lynch, C. F.
    Malone, K. E.
    Haile, R. W.
    Andersson, M.
    Thomas, D. C.
    Concannon, P.
    Capanu, M.
    Boice, J. D., Jr.
    Bernstein, J. L.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 728 - 733
  • [39] Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer
    Cybulski, Cezary
    Wokolorczyk, Dominika
    Jakubowska, Anna
    Huzarski, Tomasz
    Byrski, Tomasz
    Gronwald, Jacek
    Masojc, Bartlomiej
    Debniak, Tadeusz
    Gorski, Bohdan
    Blecharz, Pawel
    Narod, Steven A.
    Lubinski, Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) : 3747 - 3752
  • [40] A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers
    Thompson, Deborah
    Seal, Sheila
    Schutte, Mieke
    McGuffog, Lesley
    Barfoot, Rita
    Renwick, Anthony
    Eeles, Rosalind
    Sodha, Nayanta
    Houlston, Richard
    Shanley, Susan
    Klijn, Jan
    Wasielewski, Marijke
    Chang-Claude, Jenny
    Futreal, P. Andrew
    Weber, Barbara L.
    Nathanson, Katherine L.
    Stratton, Michael
    Meijers-Heijboer, Hanne
    Rahman, Nazneen
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (12) : 2542 - 2545
12345